Archives: Press Releases
Modulus Discovery, Inc. to Present at the 42nd Annual J.P. Morgan Healthcare Conference
News -
09 January, 2024 -
Modulus Discovery, Inc. (“Modulus”), a preclinical stage technology-driven drug discovery company, will present at the 42nd Annual J.P. Morgan Healthcare Conference. The J.P. Morgan Healthcare Conference, the largest and most informative healthcare investment symposium in the industry, will be held in San Francisco on January 8-11, 2024. Roy Kimura, Modulus co-founder and CEO, will present ...continuedPeptiDream and Modulus Announce Nomination of First Clinical Development Candidate from Strategic Partnership
News -
03 August, 2023 -
PeptiDream Inc., a public Kanagawa, Japan-based biopharmaceutical company (President and CEO: Patrick C. Reid, hereinafter “PeptiDream”)(Tokyo: 4587) and Modulus Discovery, Inc., a privately held Tokyo-based drug discovery company (CEO: S. Roy Kimura, hereinafter “Modulus”) today announced the nomination of the first clinical development candidate arising from the companies’ strategic drug discovery partnership. Under the companies’ ...continuedModulus Discovery has been selected as a “J-Startup” company by the Ministry of Economy, Trade and Industry of Japan
News -
06 April, 2023 -
Today, Modulus Discovery, Inc. (“the Company”) announced that the Company has been selected as a “J-Startup” company, a program supported by the Ministry of Economy, Trade and Industry of Japan (METI) to empower Japan’s startup ecosystem. For more information, please refer to the following URL. https://www.meti.go.jp/press/2023/04/20230406003/20230406003.html https://www.meti.go.jp/policy/newbusiness/j-startup2023.pdf <About “J-Startup” program> “J-Startup” was launched in ...continuedModulus Discovery, Inc. to Present at the 41st Annual J.P. Morgan Healthcare Conference
News -
13 December, 2022 -
Modulus Discovery, Inc. (“Modulus”), a preclinical stage technology-driven drug discovery company, will present at the 41st Annual J.P. Morgan Healthcare Conference. The J.P. Morgan Healthcare Conference, the largest and most informative healthcare investment symposium in the industry, will be held in San Francisco on January 8-12, 2023. Roy Kimura, Modulus co-founder and CEO, will present ...continuedModulus Discovery Announces Research Collaboration with Fujitsu on the Implementation and Optimization of ModBind™, A Novel Computational Technology for Drug Discovery
News -
08 August, 2022 -
Modulus Discovery, Inc., a computation-driven drug discovery company, announced today the signing of a research collaboration with Fujitsu Limited and the unveiling of its proprietary computational technology platform, ModBind™. The collaboration will accelerate the large-scale deployment of Modulus discovery tools across world-leading supercomputers, including the supercomputer “Fugaku”(*1), and AI Bridging Cloud Infrastructure (ABCI, *2). ModBind ...continuedModulus Discovery Closes $20.4M USD Series C
News -
01 March, 2022 -
Tokyo, Japan – Modulus Discovery, Inc., a preclinical-stage computation-driven drug discovery firm, announces the successful closing of its Series C funding round in the amount of 2.34B JPY (approximately $20.4M USD). Series C investors include Green Coinvest Investment Limited Partnership., SBI Group., Heights Capital Management, Inc., and existing shareholders including UTokyo Innovation Platform Co., Ltd., ...continuedNissan Chemical and Modulus Discovery Jointly Announce Signing of Strategic Drug Discovery Collaboration Agreement
News -
21 April, 2021 -
Nissan Chemical Corporation (Head Office: Chuo-ku, Tokyo Japan; President: Shinsuke Yagi, “Nissan Chemical”), and Modulus Discovery, Inc. (Head Office: Chiyoda-ku, Tokyo Japan; CEO: S. Roy Kimura, Ph.D., “Modulus”), an early stage global biopharmaceutical company, jointly announced today the signing of a strategic drug discovery collaboration agreement. Under this agreement, the companies will collaboratively accelerate the ...continuedModulus Discovery, Inc. to Present at the 39th Annual J.P. Morgan Healthcare Conference
News -
14 December, 2020 -
Modulus Discovery Inc. (“Modulus”), a pre-clinical stage technology-driven drug discovery company announced today that it was invited to present at the 39th Annual J.P. Morgan Healthcare Conference in January 2021. The J.P. Morgan Healthcare Conference, which attracts over 500 companies and 12,000 investors, is going virtual for 2021, and the webcast will be made available ...continued